KEYNOTE-564: Phase 3 trial of pembrolizumab in the adjuvant treatment of renal cell carcinoma (RCC)
Conference Paper
Full Text
Duke Authors
Cited Authors
- Choueiri, TK; Powles, T; Zhang, T; Quinn, DI; Gschwend, JE; Wan, SS; Poehlein, C
Published Date
- September 1, 2017
Published In
Volume / Issue
- 28 /
Published By
Pages
- 1
Electronic International Standard Serial Number (EISSN)
- 1569-8041
International Standard Serial Number (ISSN)
- 0923-7534
Conference Name
- 42nd European-Society-for-Medical-Oncology Congress (ESMO)
Conference Location
- Madrid, SPAIN
Conference Start Date
- September 8, 2017
Conference End Date
- September 12, 2017